intestin
tract
major
entri
site
virus
bacteria
mucos
innat
adapt
immun
cell
equip
respond
fight
invad
pathogen
time
intestin
lumen
dens
colon
commens
microflora
steadi
state
provok
exacerb
inflammatori
respons
intestin
lumen
separ
underli
steril
lamina
propria
harbor
bodi
largest
immun
cell
compart
singl
layer
polar
intestin
epitheli
cell
iec
epitheli
cell
layer
undergo
rapid
perpetu
selfrenew
without
disrupt
function
integr
junction
addit
iec
form
passiv
physic
barrier
also
particip
activ
immun
respons
major
enter
pathogen
cross
talk
commens
flora
howev
pathogen
virus
bacteria
parasit
exploit
opportun
breach
epitheli
barrier
upon
infect
host
cell
commun
mean
product
secret
signal
molecul
interferon
ifn
larg
famili
cytokin
divers
function
success
host
defens
famili
type
ifn
compris
member
multipl
one
import
classic
promin
function
type
ifn
induc
antivir
immun
wherea
type
ii
ifn
promot
respons
intracellular
bacteria
howev
vast
amount
studi
found
type
ifn
also
produc
bacteri
infect
contrast
action
viral
infect
activ
bacteria
either
favor
detriment
host
recent
novel
famili
ifn
type
iii
ifn
famili
describ
famili
consist
also
call
human
wherea
mice
two
function
gene
encod
two
pseudogen
similar
type
ifn
type
iii
ifn
induc
viral
infect
show
antivir
activ
howev
structur
distinct
type
ifn
interact
heterodimer
class
ii
cytokin
receptor
consist
also
call
chain
complex
chain
oppos
type
ifn
receptor
ifnar
number
studi
address
function
import
type
iii
ifn
compar
type
ifn
context
viral
infect
less
known
role
type
ifn
almost
noth
role
type
iii
ifn
host
defens
bacteri
enteropathogen
intestin
homeostasi
coliti
therefor
review
recent
progress
made
import
type
iii
ifn
enter
viral
infect
focu
role
type
ifn
intestin
mucos
tissu
steadi
state
respons
bacteri
infect
inflamm
induct
type
iii
ifn
recent
review
elsewher
therefor
briefli
summar
major
mechan
lead
ifn
express
virtual
cell
equip
machineri
recogn
viral
infect
express
type
iii
ifn
respons
similar
stimuli
pathway
lead
express
type
iii
ifn
howev
differ
cell
type
well
magnitud
kinet
describ
compar
express
pattern
type
iii
ifn
result
similar
requir
transcript
factor
express
encod
gene
ifn
regulatori
factor
irf
howev
differ
promot
region
express
reli
bind
constitut
express
promot
allow
rapid
induct
contrast
requir
bind
interferonstimul
gene
isg
need
upregul
cell
type
follow
infect
type
iii
ifn
depend
activ
requir
combin
action
irf
full
induct
system
viral
infect
hematopoiet
cell
major
sourc
type
ifn
plasmacytoid
dendrit
cell
pdc
design
profession
type
ifnproduc
cell
produc
larg
amount
respons
wide
rang
virus
parasit
bacteria
particularli
import
earli
phase
type
ifn
product
howev
depend
infecti
agent
myeloid
cell
also
involv
system
type
ifn
product
system
listeria
infect
vast
amount
system
product
independ
pdc
seem
produc
lysmcreexpress
macrophagemonocytelik
cell
includ
tipdc
neutrophil
intestin
lamina
propria
dendrit
cell
dc
well
mononuclear
phagocyt
produc
steadi
state
epitheli
cell
thought
major
produc
type
iii
ifn
steadi
state
enter
viral
infect
lamina
propria
leukocyt
lpl
also
produc
type
iii
ifn
certain
condit
intraepitheli
lymphocyt
produc
upon
tcr
activ
contribut
protect
noroviru
infect
moreov
cell
main
sourc
psoriat
lesion
skin
bacteria
trigger
similar
intracellular
signal
cascad
viral
infect
mani
bacteri
infect
lead
product
type
ifn
review
ref
induct
type
iii
ifn
demonstr
limit
number
bacteri
speci
human
epitheli
colon
cancer
cell
line
express
type
iii
ifn
upon
infect
gramposit
bacteria
listeria
monocytogen
staphylococcu
aureu
enterococcu
faecali
fail
produc
consider
amount
type
iii
ifn
infect
gramneg
bacteria
salmonella
enterica
ssp
typhimurium
shigella
flexneri
chlamydia
trachomati
induct
seem
cell
type
speci
gene
specif
bind
ifn
correspond
receptor
trigger
stimul
janu
kinas
jak
transduc
transcript
stat
pathway
type
ifn
receptor
ifnar
consist
two
subunit
engag
ifnar
ligand
ultim
result
activ
transcript
factor
complex
compris
heterodim
conjunct
subsequ
induct
isg
type
iii
ifn
receptor
consist
uniqu
chain
chain
share
receptor
engag
receptor
complex
result
activ
signal
transduct
cascad
manner
highli
similar
caus
type
ifn
signal
interestingli
signal
type
iii
ifn
addit
regul
level
receptor
express
wherea
ifnar
ubiquit
present
chain
type
iii
ifn
receptor
express
limit
number
cell
type
preferenti
locat
mucos
surfac
epitheli
cell
mucos
tissu
major
target
type
iii
ifn
addit
respons
type
iii
ifn
recent
suggest
restrict
panel
immun
cell
type
iii
ifn
propos
role
direct
regul
nk
cell
effector
function
suppress
function
type
iii
ifn
autoimmun
inflammatori
diseas
also
propos
recent
model
collageninduc
arthriti
treatment
type
iii
ifn
inhibit
recruit
neutrophil
shown
express
high
level
respond
directli
type
iii
ifn
addit
controversi
data
respons
cell
dc
monocyt
type
iii
ifn
human
cell
express
type
iii
ifn
receptor
seem
less
restrict
mous
cell
wider
panel
immun
cell
includ
b
cell
respons
type
iii
ifn
signal
ifn
induc
transcript
hundr
isg
includ
patternrecognit
receptor
antivir
effector
myxoviru
resist
mx
gene
proapoptot
gene
mhc
class
gene
induc
nitric
oxid
synthas
gene
encod
member
gtpase
superfamili
alter
matur
phagosom
counteract
pathogen
strategi
base
surviv
intracellular
compart
moreov
gene
involv
desensit
ifn
also
induc
allow
cell
recov
ifn
respons
import
ifn
immedi
defens
pathogen
shown
gener
genetarget
mice
mice
defici
compon
type
ifn
signal
transduct
pathway
highli
suscept
varieti
virus
role
type
ifn
bacteri
infect
complex
wherea
type
ifn
protect
mice
system
infect
extracellular
bacteria
test
exacerb
diseas
infect
mice
l
monocytogen
mycobacterium
tuberculosi
rotaviru
belong
famili
reovirida
infect
human
lead
sever
diarrhea
children
younger
year
suscept
infant
recapitul
mous
model
suckl
mice
highli
suscept
infect
compar
adult
mice
strict
host
cell
tropism
rotaviru
iec
make
clean
model
studi
epithelialspecif
effect
ifn
mice
infect
homolog
strain
murin
rotaviru
heterolog
strain
rhesu
simian
rotaviru
homolog
strain
better
equip
evad
host
immun
respons
gener
lead
higher
viral
titer
sever
patholog
lower
infecti
dose
protect
role
type
ifn
question
sinc
mice
impair
type
ifn
signal
infect
murin
rotaviru
strain
show
differ
viral
load
treatment
either
type
ifn
result
clinic
benefit
howev
simian
rhesu
rotaviru
show
enhanc
system
replic
mice
defici
type
ifn
receptor
contrast
type
iii
ifn
protect
homolog
infect
model
suckl
adult
mice
note
distinct
cell
tropism
type
iii
ifn
respons
intestin
report
iec
sole
activ
type
iii
ifn
respons
type
ifn
wherea
cell
lamina
propria
respond
type
ifn
induc
viral
infect
support
find
shown
augment
antivir
effect
type
iii
ifn
signal
contribut
protect
effect
homolog
rotaviru
infect
howev
model
question
anoth
studi
report
type
ifn
type
iii
ifnmedi
protect
heterolog
homolog
rotaviru
infect
suckl
mice
experiment
discrep
studi
appar
suggest
flora
differ
mous
facil
genet
strategi
knockout
mous
line
might
impact
efficaci
ifn
signal
note
lin
et
al
report
agedepend
respons
iec
toward
ifn
neonat
iec
respons
type
ifn
type
iii
ifn
wherea
adult
iec
respons
type
iii
ifn
noroviru
caus
major
nonbacteri
gastroenter
adult
contrast
rotaviru
host
cell
tropism
noroviru
broad
fulli
character
ex
vivo
vivo
studi
could
show
product
viru
replic
iec
phagocyt
allow
product
viru
replic
vivo
infect
viru
detect
lpl
although
viru
replic
iec
suggest
transloc
across
epithelium
enter
host
via
cell
type
ifn
restrict
murin
noroviru
replic
macrophag
dc
vitro
vivo
antivir
activ
type
ifn
mediat
protect
system
replic
acut
strain
highdos
oral
infect
howev
local
replic
colon
fecal
shed
persist
noroviru
strain
control
type
iii
ifn
treatment
type
iii
ifn
resolv
persist
infect
independ
adapt
immun
respons
act
nonhematopoiet
cell
contrast
type
ifn
control
system
spread
persist
acut
noroviru
strain
activ
host
dc
find
demonstr
distinct
celltyp
specif
type
ifn
type
iii
ifn
infect
local
protect
colon
type
iii
ifn
stimul
epitheli
cell
prevent
system
spread
persist
type
ifn
myeloid
cell
commens
bacteri
flora
report
promot
noroviru
persist
intestin
antibiot
treatment
mice
prevent
persist
infect
noroviru
protect
effect
observ
presenc
function
type
iii
ifn
signal
antibiot
treatment
alter
type
iii
ifn
signal
therefor
author
conclud
microflora
might
render
viru
suscept
antivir
action
type
iii
ifn
altern
absenc
type
iii
ifn
signal
might
increas
host
vulner
persist
viral
infect
dramat
minor
chang
antibiot
treatment
impact
overal
suscept
condit
reoviru
broad
host
cell
tropism
replic
epitheli
cell
immun
cell
intestin
mucosa
oral
infect
enter
host
via
cell
peyer
patch
spread
infect
type
ifn
produc
hematopoiet
cell
essenti
limit
system
spread
viru
prevent
lethal
studi
use
type
ifn
type
iii
ifn
signalingdefici
mice
demonstr
type
iii
ifn
signal
specif
prevent
replic
viru
iec
wherea
type
ifn
signal
limit
replic
lamina
propria
cell
system
spread
viru
studi
confirm
compartment
action
ifn
intestin
mucosa
provid
explan
show
iec
express
low
level
ifnar
figur
furthermor
shown
product
ifn
cell
type
specif
iec
produc
higher
level
type
iii
ifn
lpl
predominantli
produc
type
ifn
taken
togeth
studi
enter
viral
model
rotaviru
reoviru
noroviru
show
strong
specif
respons
iec
type
iii
ifn
therefor
type
iii
ifn
might
specif
enforc
intestin
barrier
enter
virus
also
viral
entri
via
intestin
rout
addit
strong
ifn
respons
type
iii
ifn
signal
within
epitheli
line
prevent
viral
spread
studi
show
type
iii
ifn
treatment
protect
oral
emcv
infect
system
infect
support
conclus
type
iii
ifn
protect
host
enter
virus
also
viral
entri
via
oral
rout
contrast
contribut
type
ifn
epitheli
antivir
respons
intestin
less
clear
conflict
result
suggest
context
depend
pioneer
studi
unravel
potenti
detriment
action
type
ifn
antibacteri
respons
perform
use
system
infect
model
l
monocytogen
review
ref
recent
studi
howev
propos
impact
type
ifn
outcom
diseas
depend
rout
infect
mice
defici
resist
system
infect
l
monocytogen
wildtyp
mice
number
mechanist
explan
phenotyp
exist
includ
increas
death
crucial
effector
cell
macrophag
cell
respons
type
ifn
signal
upregul
type
ifndepend
manner
limit
protect
inflammatori
respons
neg
cross
talk
type
ifn
signal
contrast
clear
detriment
effect
type
ifn
system
l
monocytogen
infect
role
type
ifn
oral
l
monocytogen
infect
address
limit
number
studi
mainli
due
lack
suitabl
mous
model
uptak
iec
specif
interact
listeria
virul
factor
internalina
inla
ecadherin
express
iec
requir
inla
recogn
ecadherin
human
fail
bind
correspond
domain
murin
ecadherin
knockin
mous
ubiquit
express
human
ecadherin
provid
model
oral
listeria
challeng
infect
germfre
coloni
mous
line
develop
system
listerosi
dampen
administr
lactobacilli
lactobacilli
treatment
downregul
immun
gene
express
particular
isg
among
highli
induc
gene
l
monocytogen
infect
kernbauer
et
al
use
murin
l
monocytogen
strain
express
alter
inla
recogn
mous
ecadherin
show
sharp
contrast
system
infect
type
ifn
signal
respons
highdos
lowdos
intragastr
l
monocytogen
infect
benefici
host
diminish
restrict
bacteri
growth
absenc
type
ifn
signal
result
exacerb
hepat
inflamm
damag
differ
result
obtain
recent
studi
use
egd
deriv
strain
express
murin
inla
contrast
system
infect
lead
strong
type
ifn
secret
oral
infect
strain
trigger
robust
type
ifn
induct
splenocyt
even
compar
bacteri
burden
present
spleen
neither
major
cell
deplet
increas
splenic
product
observ
model
detect
infectioninduc
downregul
receptor
dc
macrophag
depend
type
ifn
signal
consequ
major
differ
wildtyp
mice
oral
infect
l
monocytogen
detect
studi
discrep
kernbauer
pitt
studi
might
explain
differ
applic
method
intragastr
infect
compar
natur
feed
use
differ
strain
type
ifn
hyperinduc
versu
egd
addit
differ
microbiota
due
hous
condit
might
influenc
outcom
infect
salmonella
enterica
serovar
typhimurium
caus
gastroenter
one
frequent
caus
bacteri
foodborn
diseas
western
countri
repres
major
econom
problem
oral
infect
laboratori
mice
typhimurium
caus
typhoidlik
symptom
without
clinic
sign
gastroenter
use
studi
genet
determin
system
infect
mice
show
increas
resist
typhimurium
lethal
bacteri
spread
model
natur
microbiota
mous
gut
abl
outcompet
salmonella
occupi
ecolog
nich
thu
new
model
typhlocol
develop
employ
streptomycin
treatment
deplet
commens
bacteria
overcom
colon
resist
mice
infect
model
lead
rapid
induct
inflamm
cecum
colon
influenc
type
ifn
signal
immun
respons
typhimurium
infect
suggest
analysi
mice
deubiquin
proteas
deisgyl
activ
specif
also
limit
activ
thu
involv
neg
regul
type
ifn
signal
system
salmonella
infect
increas
activ
correl
impair
activ
reduc
product
mutant
mice
suscept
system
ie
typhoid
typhimurium
infect
contrast
streptomycininduc
model
typhlocol
mutant
mice
display
lower
patholog
score
low
product
upregul
type
ifn
signal
compar
control
mice
result
earlier
system
dissemin
bacteria
decreas
surviv
interestingli
influenzainduc
type
ifn
suppress
host
intestin
immun
lead
increas
suscept
secondari
salmonellainduc
coliti
influenzainduc
type
ifn
strongli
inhibit
induct
antimicrobi
inflammatori
gene
respons
secondari
typhimurium
infect
caus
increas
intestin
colon
increas
bacteri
dissemin
reduc
immunopatholog
summari
studi
suggest
detriment
effect
type
ifn
growth
dissemin
bacteria
salmonellainduc
typhlocol
wherea
limit
intestin
inflamm
effect
obiv
type
ifn
product
boost
influenza
infect
polyi
c
treatment
addit
studi
requir
determin
direct
indirect
effect
type
ifn
typhimuriuminduc
typhlocol
moreov
role
type
iii
ifn
model
yet
address
role
type
iii
ifn
enter
bacteri
infect
eg
enteropathogen
epec
enterohemorrhag
ehec
escherichia
coli
citrobact
rodentium
campylobact
jejuni
yersinia
enterocolitica
extens
address
vivo
infect
model
citrobact
rodentium
epec
develop
immun
evas
strategi
target
type
ifn
signal
suggest
protect
effect
type
ifn
pathogen
c
rodentium
report
activ
inhibit
epitheli
type
ifn
product
employ
mechan
depend
type
iii
secret
system
furthermor
also
reduc
type
ifn
signal
decreas
nuclear
transloc
phosphoryl
even
costimul
infect
colon
cancer
cell
line
epec
result
modest
product
regul
tight
junction
protein
claudin
occludin
maintain
barrier
function
use
distinct
mechan
c
rodentium
epec
effector
nled
reduc
induct
inhibit
rnase
l
ultim
result
evas
antibacteri
activ
disrupt
barrier
function
type
ifn
also
play
protect
role
oral
enterocolitica
infect
trifdefici
mice
highli
suscept
enterocolitica
infect
increas
bacteri
spread
lethal
could
prevent
treatment
trifdefici
mice
ifnar
block
wildtyp
mice
recapitul
increas
bacteri
burden
campylobact
jejuni
infect
murin
dc
lead
activ
secret
type
ifn
cooper
signal
pathway
requir
full
prime
abil
interestingli
product
type
ifn
cytokin
splenic
tissu
significantli
increas
lipooligosaccharid
lo
sialyl
whether
type
ifn
andor
type
iii
ifn
respons
sialyl
c
jejuni
role
oral
infect
model
mice
await
investig
recent
novel
mous
model
develop
reli
erad
modif
murin
gut
microbiota
use
broadspectrum
antibiot
treatment
subsequ
reassoci
complex
human
microbiota
approach
lead
stabl
colon
c
jejuni
proinflammatori
respons
colon
infect
mice
hope
model
provid
necessari
tool
answer
question
vivo
import
type
ifn
andor
type
iii
ifn
mucos
immun
respons
c
jejuni
particular
import
sinc
type
ifn
respons
also
observ
former
c
jejuniinfect
patient
suffer
syndrom
gb
autoimmun
neuropathi
infect
c
jejuni
common
predispos
factor
c
jejuni
lo
activ
high
respons
dc
isol
former
gb
patient
hypothes
influenc
develop
gb
inde
although
strong
variabl
dc
respons
lo
observ
frequenc
type
ifn
high
respond
significantli
increas
c
jejunirel
former
gb
patient
compar
control
intestin
homeostasi
depend
tight
interplay
host
commens
flora
flora
directli
protect
host
intestin
pathogen
competit
nutrient
space
furthermor
commens
bacteria
import
develop
immun
system
mainten
barrier
host
immun
system
also
great
influenc
composit
microbiota
sever
studi
suggest
ifn
signal
influenc
cross
talk
host
flora
long
recogn
microbiota
differ
inbr
mous
strain
chang
time
despit
share
origin
attribut
host
genet
factor
geneexpress
analysi
colon
mucosa
reveal
ifnrespons
gene
differenti
regul
differ
mous
strain
might
thu
contribut
microbiota
regul
inde
microbiota
analysi
mice
select
ablat
type
ifn
signal
intestin
epithelium
reveal
chang
microbiota
composit
litterm
hous
separ
week
howev
known
whether
direct
effect
type
ifn
signal
epithelium
mechanist
relationship
commun
stabil
gut
microbiota
might
also
depend
ifn
signal
mice
unabl
respond
either
type
ifn
type
iii
ifn
display
significantli
higher
tempor
variat
wildtyp
mice
accompani
increas
presenc
cell
neutrophil
howev
mice
classic
unabl
respond
type
ifn
type
iii
ifn
significantli
differ
wildtyp
mice
implic
previous
unrecogn
pathway
might
involv
inde
role
noncanon
ifn
signal
beyond
ifn
respons
suggest
recent
deriu
et
al
report
system
influenzainduc
type
ifn
product
significantli
alter
intestin
microbiota
profil
experiment
condit
uninfect
wildtyp
mice
display
similar
fecal
microbi
commun
influenza
infectioninduc
type
ifn
signal
result
deplet
indigen
segment
filament
bacteria
enhanc
colon
enterobacteriacea
type
iii
ifn
signal
strong
effect
flora
composit
rdna
sequenc
region
fecal
pellet
wildtyp
mice
reveal
similar
bacteri
class
composit
import
note
microbiota
studi
difficult
control
gener
one
specif
studi
drawn
care
major
differ
found
mous
facil
upon
colon
germfre
mice
twocompon
bacteri
commun
ifnrespons
gene
strongli
upregul
cecal
epithelia
sever
studi
also
demonstr
role
commensalinduc
tonic
type
ifn
signal
steadi
state
keep
host
state
alert
system
viral
infect
mononuclear
phagocyt
isol
nonmucos
lymph
node
germfre
mice
unabl
upregul
type
ifn
gene
stimul
microbi
ligand
thu
fail
prime
nk
cell
antivir
immun
second
studi
came
similar
conclus
demonstr
decreas
antivir
gene
express
defect
isg
express
macrophag
antibiotictr
mice
natur
commens
bacteri
speci
microbi
product
respons
tonic
type
ifn
product
unknown
identif
remain
futur
challeng
recent
connect
increas
suscept
liver
cirrhosi
patient
bacteri
infect
tonic
type
ifn
signal
made
murin
model
liver
fibrosi
transloc
gut
bacteria
induc
express
tonic
type
ifn
signatur
liver
turn
condit
myeloid
cell
produc
vast
amount
type
ifn
upon
subsequ
system
infect
l
monocytogen
type
ifn
signal
result
product
myeloid
cell
hamper
antibacteri
immun
key
find
murin
model
type
ifn
signatur
cirrhot
liver
myeloid
product
could
also
recapitul
human
patient
materi
thu
tonic
type
ifn
signal
induc
transloc
gut
microbiota
also
detriment
effect
plasmacytoid
dendrit
cell
known
import
produc
type
ifn
viral
infect
treatment
bacteri
nucleic
acid
interestingli
pdc
deriv
peyer
patch
incap
produc
signific
amount
type
ifn
stimul
cpgenrich
oligodeoxynucleotid
produc
thu
although
tonic
type
ifn
product
myeloid
cell
fulfil
import
function
maintain
basal
level
isg
mucos
microenviron
prevent
product
vast
amount
type
ifn
prevent
harm
immun
respons
commens
microorgan
sourc
type
ifn
galt
stromal
cell
inde
stromaderiv
type
ifn
shown
induc
april
baff
express
pdc
facilit
cellindepend
iga
product
mucos
b
cell
note
express
isg
steadi
state
seem
driven
type
ifn
type
iii
ifn
cell
typespecif
manner
cell
lamina
propria
mainli
activ
type
ifn
wherea
iec
respond
mainli
baselin
level
type
iii
ifn
due
low
ifnar
express
iec
accord
respons
pattern
observ
viral
infect
figur
furthermor
role
alter
type
ifn
signal
iec
address
sever
group
tschurtschenthal
colleagu
report
lack
type
ifn
signal
iec
lead
hyperprolif
phenotyp
particularli
secretori
cell
type
paneth
goblet
cell
expand
set
iec
cell
impair
type
ifn
signal
villincr
ifnarflfl
although
studi
suggest
type
ifn
signal
occur
iec
prolif
phenotyp
secondari
due
alter
microflora
cohous
mice
resolv
differ
katlinskaya
et
al
use
model
decreas
ifnar
degrad
iec
studi
type
ifn
signal
outcom
iec
phosphoryl
subsequ
lead
degrad
genet
ablat
iec
lead
increas
ifnar
level
elev
type
ifn
signal
epithelium
defici
also
result
activ
lead
hyperprolifer
epithelium
loss
barrier
function
type
ifn
signal
addit
block
elev
type
ifn
signal
howev
inhibit
prolifer
induc
apoptosi
maintain
barrier
integr
anoth
model
chronic
elev
level
system
type
ifn
epitheli
cell
turnov
increas
variou
tissu
includ
intestin
effect
due
direct
signal
type
ifn
epitheli
cell
induct
macrophag
stromal
cell
subsequ
promot
turnov
epitheli
cell
taken
togeth
epitheli
type
ifn
signal
seem
pleiotrop
effect
depend
level
receptor
express
ligand
abund
microflora
tissu
context
experi
employ
differ
murin
model
coliti
dextran
sodium
sulfat
dss
coliti
cell
transfer
model
provid
complex
pictur
role
type
iiii
ifn
intestin
inflamm
administr
dss
drink
water
lead
disrupt
epitheli
barrier
inflammatori
reaction
microbi
pattern
food
antigen
cell
transfer
model
hand
reli
transfer
naiv
cell
immunedefici
mice
eg
mice
undergo
activ
prolifer
respons
microbi
product
provok
inflammatori
coliti
suppress
cell
popul
treg
absent
katakura
et
al
investig
role
type
ifn
induct
administr
cpg
odn
experiment
coliti
mice
defici
type
ifn
signal
resist
cpg
odnmedi
effect
suscept
dss
treatment
wildtyp
mice
suggest
protect
effect
type
ifn
signal
contrast
therapeut
approach
employ
transgen
lactobacillu
acidophilu
strain
constitut
express
fail
protect
dssinduc
coliti
exacerb
diseas
colit
mice
pretreat
display
increas
product
proinflammatori
cytokin
decreas
number
treg
small
intestin
vitro
matur
bonemarrowderiv
dc
result
threefold
reduct
impair
abil
induc
treg
thu
although
correl
downregul
dc
exacerb
coliti
observ
pretreat
colit
mice
surprisingli
also
result
increas
intestin
damag
result
suggest
tight
regul
type
ifn
signal
import
balanc
intestin
homeostasi
effect
type
ifn
experiment
coliti
might
depend
sever
inflamm
oppos
role
specif
phase
intestin
damag
inflamm
propos
high
dss
concentr
type
ifn
signal
protect
acut
intestin
damag
presum
suppress
releas
colon
mhc
class
ii
cell
recoveri
phase
dss
treatment
type
ifn
signal
result
delay
recoveri
intestin
inflamm
accompani
increas
cell
apoptosi
well
increas
chemokin
product
subsequ
infiltr
neutrophil
inflammatori
monocyt
potenti
type
ifn
signal
either
suppress
acut
coliti
delay
recoveri
might
provid
explan
vari
effect
type
ifn
treatment
inflammatori
bowel
diseas
ibd
patient
sever
group
analyz
effect
type
ifn
signal
cell
suggest
regul
intestin
homeostasi
highli
express
intestin
cell
steadi
state
driven
microflora
induc
type
ifn
signal
poli
c
treatment
cell
transfer
coliti
attenu
coliti
ifnardepend
induct
cell
lead
downregul
proinflammatori
cytokin
level
furthermor
lee
et
al
identifi
protect
role
cell
type
ifn
signal
regul
express
suppress
effect
treg
wherea
treg
isol
wildtyp
mice
suppress
coliti
cotransf
cell
cell
popul
deriv
mice
fail
although
treg
undergo
normal
develop
mice
cell
acquir
dysfunct
phenotyp
accompani
reduc
express
cotransf
naiv
cell
recipi
administr
recombin
amelior
tcelldepend
coliti
augment
number
treg
suggest
potenti
therapeut
applic
type
ifn
intestin
inflamm
contrast
sever
studi
suggest
indirect
effect
ligand
type
ifn
signal
protect
cellmedi
experiment
coliti
role
b
cell
exclud
colitisreduc
effect
cpg
odn
mediat
cell
requir
function
type
ifn
signal
model
cell
transfer
coliti
kole
et
al
show
colon
mononuclear
phagocyt
defici
type
ifn
signal
fail
produc
regulatori
cytokin
respons
tlr
activ
furthermor
cell
transfer
coliti
model
ifnar
signal
host
hematopoiet
cell
import
limit
effector
cell
expans
promot
stabil
treg
intestin
epitheli
cell
particular
paneth
cell
also
propos
target
type
ifn
signal
intestin
paneth
cell
epitheli
cell
locat
base
smallintestin
crypt
special
secret
antimicrobi
peptid
factor
sustain
epitheli
stem
cell
progenitor
cell
mice
specif
delet
iec
display
expans
paneth
cell
number
epitheli
hyperprolifer
compar
wildtyp
litterm
although
epithelialspecif
delet
impact
sever
spontan
dssinduc
intestin
inflamm
exhibit
increas
tumor
burden
azoxymethanedss
model
colitisassoci
colon
cancer
spontan
epitheli
hyperprolifer
tumor
promot
depend
microbi
flora
sinc
differ
wildtyp
iecspecif
mice
appar
mice
hous
separ
human
murin
iec
display
high
respons
type
iii
ifn
treatment
recent
studi
demonstr
protect
role
type
iii
ifn
signal
dssinduc
coliti
mice
defici
type
iii
ifn
receptor
lost
significantli
weight
suffer
significantli
increas
intestin
damag
dss
treatment
compar
wt
control
addit
loss
type
ifn
receptor
chang
patholog
score
compar
singl
loss
type
iii
ifn
receptor
emphas
promin
role
type
iii
ifn
signal
model
protect
effect
type
iii
ifn
signal
independ
potenti
chang
microbiota
sinc
result
obtain
wildtyp
type
iii
ifn
signalingdefici
mice
cohous
week
ibd
compris
crohn
diseas
cd
ulcer
coliti
uc
chronic
debilit
inflammatori
disord
gastrointestin
tract
ibd
affect
western
popul
current
cure
typic
requir
longterm
treatment
immun
suppress
agent
mani
case
surgic
intervent
although
etiolog
remain
unclear
ibd
thought
aris
due
aberr
immun
respons
compon
commens
bacteri
microbiota
recent
genomewid
associ
studi
identifi
genet
suscept
loci
ibd
affect
gene
involv
immun
barrier
function
mani
singlenucleotid
polymorph
snp
found
gene
associ
pathogen
cytokin
circuit
circuit
type
ifni
signal
major
signal
mediat
share
differ
cytokin
signal
cascad
therefor
exact
determin
relev
pathway
imposs
genet
data
interestingli
sever
ibdassoci
gene
also
involv
type
ifn
signal
pathway
snp
commonli
associ
gene
could
also
affect
gene
gene
harbor
identifi
snp
signal
mediat
mani
cytokin
pathway
also
type
iiii
ifn
furthermor
polymorph
gene
might
alter
product
type
iiii
ifn
although
type
ifn
signal
network
one
major
player
ibd
patholog
slight
alter
may
contribut
imbalanc
immun
respons
lamina
propria
suggest
mous
studi
inde
gile
colleagu
analyz
respons
cell
healthi
control
ibd
patient
found
signal
modul
colon
cell
respons
contextdepend
manner
human
colon
cell
respons
exogen
endogen
influenc
cytokin
profil
ex
vivo
cultur
cell
cell
healthi
control
produc
decreas
level
absenc
signal
wherea
cell
ibd
patient
produc
elev
level
proinflammatori
cytokin
approv
treatment
multipl
sclerosi
ms
howev
subset
patient
respond
treatment
axtel
colleagu
analyz
effect
differ
th
subset
found
treatment
mous
model
eae
attenu
diseas
develop
patholog
effect
even
exacerb
patholog
diseas
furthermor
could
correl
high
serum
level
ms
patient
nonrespons
toward
treatment
find
confirm
immunomodulatori
role
also
demonstr
divers
consequ
differ
context
oppos
effect
within
set
despit
vari
result
mous
studi
role
type
ifn
coliti
discrep
type
ifn
effect
suppress
acut
coliti
delay
recoveri
type
ifn
suggest
treatment
ibd
sever
small
studi
evalu
consequ
ibd
patient
vari
result
although
small
pilot
studi
suggest
benefici
outcom
type
ifn
treatment
ibd
patient
placebocontrol
doubleblind
studi
crohn
patient
remiss
find
improv
treatment
mainten
remiss
also
two
random
placebocontrol
studi
uc
patient
activ
diseas
could
show
benefici
effect
treatment
diseas
remiss
small
studi
analyz
cytokin
level
treatment
found
correl
respons
reduct
level
uc
patient
unrespons
treatment
correl
elev
level
accord
find
ms
patient
taken
togeth
studi
support
benefici
outcom
type
ifn
treatment
ibd
conclus
also
drawn
recent
intervent
review
analyz
trial
data
publish
effect
type
ifn
treatment
remiss
uc
patient
howev
consid
analysi
nonrespons
patient
ms
contextspecif
respons
cell
toward
type
ifn
controversi
find
mous
studi
effect
treatment
might
vari
th
profil
patient
care
preselect
patient
would
requir
studi
suffici
patient
number
thorough
analysi
immunolog
diseas
paramet
requir
celiac
diseas
smallintestin
enteropathi
character
aberr
cellmedi
immun
respons
suscept
individu
dietari
gluten
pathogen
adapt
immun
respons
initi
interplay
gluten
mhc
class
ii
molecul
character
potent
respons
excess
tissu
destruct
driven
sever
iel
hyperplasia
target
iec
histolog
celiac
diseas
character
villou
flatten
crypt
hyperplasia
iel
infiltr
affect
individu
present
variabl
symptom
rang
asymptomat
sever
symptom
ascrib
impair
absorpt
nutrient
strongest
genet
factor
diseas
howev
recogn
immuneregulatori
activ
factor
requir
diseas
establish
sever
celiac
diseas
suscept
loci
gene
associ
innat
immun
respons
identifi
suggest
role
innat
immun
develop
diseas
influenc
type
ifn
develop
celiac
diseas
wide
discuss
inde
number
case
studi
report
develop
diarrhea
onset
celiac
diseas
treatment
chronic
hepat
c
patient
retrospect
studi
hepat
c
patient
without
symptom
celiac
diseas
show
activ
silent
celiac
diseas
major
patient
posit
transglutaminas
antibodi
ifn
therapi
immunomodulatori
properti
type
ifn
might
worsen
underli
autoimmun
disord
monitor
hepat
c
patient
celiac
diseas
start
ifn
therapi
suggest
potenti
role
cotreat
ribavirin
promot
immun
respons
suppress
respons
also
discuss
high
preval
celiac
diseas
hcv
patient
treat
investig
studi
includ
chronic
hepat
c
patient
studi
fail
detect
signific
associ
celiac
diseas
hcv
infect
addit
came
conclus
therapi
per
se
trigger
celiac
diseas
patient
neg
endomysium
ema
tissu
transglutaminas
howev
rule
treatment
might
trigger
develop
celiac
diseas
suscept
individu
investig
underli
mechan
explant
cultur
human
fetal
gut
analyz
activ
cell
singl
treatment
either
alon
trigger
profound
chang
combin
result
enhanc
respons
crypt
cell
hyperplasia
associ
enhanc
fyn
phosphoryl
treatment
might
thu
facilit
activ
cell
trigger
immunopatholog
onset
celiac
diseaselik
symptom
also
observ
case
chronic
myeloid
leukemia
treat
suggest
role
type
ifn
promot
respons
gluten
also
protein
detect
duoden
tissu
celiac
diseas
patient
control
sampl
studi
requir
determin
whether
direct
link
exist
type
ifn
signal
celiac
diseas
although
import
progress
made
recent
year
addit
studi
requir
deepen
understand
role
type
ifn
type
iii
ifn
gut
type
ifn
signal
enter
viral
infect
mostli
protect
wherea
detriment
certain
enter
bacteri
infect
clinic
data
use
type
ifn
coliti
treatment
partli
contradictori
larger
number
patient
requir
obtain
conclus
result
except
viral
infect
coliti
model
type
iii
ifn
signal
mostli
protect
data
illumin
role
type
iii
ifn
signal
gut
gener
scarc
well
establish
epitheli
cell
especi
respons
type
iii
ifn
enforc
mucos
barrier
prevent
viral
entri
infect
less
clear
nonrespons
epithelium
type
ifn
observ
sever
condit
figur
benefit
epitheli
cell
gain
decreas
respons
receptor
express
level
local
fulli
explain
reduc
type
ifn
respons
epithelium
narrow
rang
cell
respond
type
iii
ifn
make
attract
target
futur
clinic
studi
increas
specif
fewer
side
effect
type
ifn
jp
sst
wrote
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
